Pollen Allergy Market Report 2025

This Pollen Allergy market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The pollen allergy market size has grown strongly in recent years. It will grow from $6.92 billion in 2024 to $7.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the historic period can be attributed to several factors, including increased awareness of allergic conditions, higher investments in healthcare infrastructure, the impact of climate change resulting in longer pollen seasons, and the rise in urbanization, which has led to greater exposure to allergens.

The pollen allergy market size is expected to see strong growth in the next few years. It will grow to $10.26 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth anticipated during the forecast period can be attributed to several factors, including the rising prevalence of allergic conditions, increasing pollution levels, the ongoing effects of climate change, greater awareness of allergy treatments, the expanding availability of treatment options, improved healthcare access, and a heightened focus on preventive measures and environmental health. Key trends during this period include the development of more effective immunotherapy treatments, the adoption of personalized allergy medications, innovations in pollen-blocking nasal filters, advancements in air purifiers equipped with HEPA filters, improvements in nasal spray formulations, the growing popularity of natural and organic allergy relief products, and the advancement of wearable devices that monitor allergen exposure in real-time.

The increasing prevalence of allergic rhinitis is expected to drive the growth of the pollen allergen market. Allergic rhinitis is a condition that causes inflammation in the nose, leading to symptoms such as sneezing, nasal congestion, and itchy eyes, often triggered by pollen or dust. The rise in allergic rhinitis is linked to factors such as environmental pollution, climate change, urbanization, and lifestyle changes, which increase exposure to allergens and pollutants. This condition is commonly caused by pollen allergies, where contact with pollen leads to inflammation in the nasal passages. For example, in October 2023, the World Allergy Organization, a US-based organization focused on clinical allergic studies, reported that allergic rhinitis affects more than 400 million people worldwide, with prevalence rates ranging from 10% to 30% in adults and surpassing 40% in children. As a result, the growing prevalence of allergic rhinitis is driving the expansion of the pollen allergen market.

Leading companies in the pollen allergy market are focusing on creating comprehensive allergy care platforms that offer integrated solutions for the diagnosis, treatment, and management of allergies, ensuring better patient outcomes and convenience. A comprehensive allergy care platform for pollen allergy is an all-encompassing system or service designed to support individuals with pollen allergies from start to finish. For example, in February 2023, Nectar Life Sciences, a pharmaceutical company based in India, launched Nectar, a comprehensive allergy care platform, and introduced personalized sublingual immunotherapy drops as its first product. These custom-formulated Nectar allergy drops are based on a CLIA-certified at-home allergy test and target the root cause of allergies. They provide a convenient and effective alternative to traditional treatments such as shots and antihistamines. The program simplifies the treatment process with home delivery and ongoing prescriptions every three months, helping patients with moderate to severe allergies build long-term tolerance and reduce symptoms. This innovative approach aims to transform allergy care by combining personalization, convenience, and proven effectiveness.

In September 2023, Stallergenes Greer International AG, a pharmaceutical company based in Switzerland, acquired the peanut allergy oral immunotherapy treatment Palforzia from Nestlé S.A. for an undisclosed sum. This acquisition enhances Stallergenes’ position as a leader in allergen immunotherapy by broadening its portfolio to include both respiratory and food allergy treatments. Nestlé S.A., a Swiss food and beverage company, is actively involved in addressing a range of allergies, including food and environmental allergies such as those related to pollen.

Major players in the pollen allergy market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd, Genentech Inc., Omega Pharma, ALK Abello, Stallergenes Greer, Aimmune Therapeutics, Allergy Therapeutics, McNeil Consumer Healthcare, Meda Pharmaceuticals Inc, HAL Allergy Group, Allergopharma, Biomay AG, Leti Pharma, Epigenomics AG, Alerpharma S.A.

North America was the largest region in the pollen allergy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pollen allergy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pollen allergy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pollen allergy is an immune system response to pollen from trees, grasses, and weeds. It occurs when the immune system mistakenly identifies pollen as harmful, triggering the release of chemicals such as histamine. Pollen allergies are typically seasonal, with symptoms peaking in spring, summer, or fall, depending on the type of pollen an individual is allergic to.

The pollen allergy market includes key product categories such as instruments, consumables, and services. Instruments are medical devices used for diagnosing, monitoring, and treating pollen allergies. Examples include nasal irrigation devices, allergy testing equipment, and inhalers. Allergens are classified into food, inhaled, drug, and other types. Treatments for pollen allergies encompass antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto-injectable epinephrine, and immunotherapy. These products are mainly used in diagnostic laboratories and hospitals.

The pollen allergy market research report is one of a series of new reports that provides pollen allergy market statistics, including the pollen allergy industry's global market size, regional shares, competitors with a pollen allergy market share, detailed pollen allergy market segments, market trends and opportunities, and any further data you may need to thrive in the pollen allergy industry. This pollen allergy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pollen allergy market consists of sales of nasal sprays, eye drops, allergy masks, air purifiers, and pollen blockers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.